TY - JOUR
T1 - Surgical management of pancreatic cancer.
AU - Ahrendt, Steven A.
AU - Pitt, Henry A.
PY - 2002/6
Y1 - 2002/6
N2 - Pancreatic cancer is the fifth leading cause of cancer death in the United States, with an overall survival rate of 3%. Unfortunately, only a minority of patients present with localized disease amenable to surgical resection. Over the past 20 years, improvements in operative and perioperative management have led to a decrease in operative mortality, shorter hospital stay, and overall 5-year survival of approximately 20% in patients undergoing pancreaticoduodenectomy. Despite advances in nonoperative palliation, surgery continues to play an important role in the management of patients with locally advanced, unresectable pancreatic cancer.
AB - Pancreatic cancer is the fifth leading cause of cancer death in the United States, with an overall survival rate of 3%. Unfortunately, only a minority of patients present with localized disease amenable to surgical resection. Over the past 20 years, improvements in operative and perioperative management have led to a decrease in operative mortality, shorter hospital stay, and overall 5-year survival of approximately 20% in patients undergoing pancreaticoduodenectomy. Despite advances in nonoperative palliation, surgery continues to play an important role in the management of patients with locally advanced, unresectable pancreatic cancer.
UR - http://www.scopus.com/inward/record.url?scp=0036599065&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036599065&partnerID=8YFLogxK
M3 - Review article
C2 - 12088296
AN - SCOPUS:0036599065
SN - 0890-9091
VL - 16
SP - 725-734; discussion 734, 736-738, 740, 743
JO - Oncology (Williston Park, N.Y.)
JF - Oncology (Williston Park, N.Y.)
IS - 6
ER -